Navigating the Maze: Applying Evidence-Based Strategies to Improve Treatment Response in MDD

Jointly provided by AXIS Medical Education and Novus Medical Education.

This activity is supported by an independent education grant from Otsuka America Pharmaceutical, Inc.

Specialty: Neurology

Target Audience: This activity is intended for psychiatrists and other mental health professionals who provide care for patients suffering from depression.

Program Overview: Major depressive disorder (MDD) is a debilitating condition that approximately 1 in 5 people in the United States will experience at some point in their life, yet up to 60% of patients do not attain an adequate response from their initial antidepressant treatment. Clinicians have historically struggled to agree on when a patient should be considered non- or partially-responsive, and the APA’s practice guidelines for treating patients with MDD stops short of providing a definitive answer. It is critical for clinicians to recognize when a modification to therapy should be made, and to have the decision making skills to evaluate and select appropriate alternatives.

This series consists of 2 continuing education modules


Module 1


Module 2 Patient Case: Suzanne, 45, Suffering from Depression